Acute inflammatory biomarkers in cerebrospinal fluid as indicators of blood cerebrospinal fluid barrier damage in Japanese subjects with infectious meningitis

Clinical Laboratory

Volumn 57, Issue 1-2, 2011, Pages 37-46

  Kanoh, Yuhsaku ^a   Ohara, Tadashi ^b   Akahoshi, Tohru ^a  

^a KITASATO UNIVERSITY   (Japan)

^b International University of Health and Welfare Hospital   (Japan)

Author keywords

2 macroglobulin; Albumin; Blood cerebrospinal fluid barrier; C reactive protein; Interleukin 6; Serum amyloid A

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SERUM AMYLOID A;

ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CIRCULATION DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; FUNGAL MENINGITIS; HUMAN; INFLAMMATION; JAPANESE; MENINGITIS; MOLECULAR WEIGHT; PROTEIN CEREBROSPINAL FLUID LEVEL; ADULT; BACTERIAL MENINGITIS; BLOOD; BLOOD BRAIN BARRIER; FEMALE; IMMUNOLOGY; JAPAN; MALE; PATHOLOGY; VIRUS MENINGITIS;

BACTERIA (MICROORGANISMS);

ADULT; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; FEMALE; HUMANS; INTERLEUKIN-6; JAPAN; MALE; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; SERUM AMYLOID A PROTEIN;

EID: 79953810949     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorder. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
2. Link H, Tibbing G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 1977;37:391-6. (Pubitemid 8387872)
3. Meucci G, Rossi G, Bettini R, Montanaro D, Gironelli L, Voci L, Bianchi F. Laser-nepherometric evaluation of albumin, IgG and α2 macroglobulin: applications of the study of alterations of the blood-brain barrier. J Neurol Sci 1993;118:73-8. (Pubitemid 23269969)
4. Kanoh Y and Hideki O. Levels of Interleukin-6, CRP and α2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage. Biochem Mol Bio Int 1997; 269-78.
5. Kanoh Y and Hideki O. Protein abnormalities in CSF and blood under blood-cerebrospinal fluid barrier damage. Jpn J Electrophor 1996;40:199-206.
6. Matsuda T, Hirano T, Nagasawa S, Kitamoto T. Identification of α2 macroglobulin as a carrier protein for IL-6. J Immunol 1989; 142:148-52. (Pubitemid 19034735)
7. Yoshitake F, Itoh S, Narita H, Ishihara K, Ebisu S. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappa B signaling pathway. J Biol Chem 2008;283(17):11535-40.
8. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001;27(1):211-5. (Pubitemid 32208990)
9. Kocabas E, Sarikcioglu A, Aksaray N, Seydaoglu G, Seyhun Y, Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr 2007;49(1):7-20. (Pubitemid 46585449)
10. Miida T, Yamada T, Seino U, et al. Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta 2006; 1761(4):424-33. (Pubitemid 43776455)
11. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993; 39(2):293-7. (Pubitemid 23069690)
12. Lannergard A, Larsson A, Kragsbjerg P, Friman G. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest 2003;63(4):267-72. (Pubitemid 37006434)
13. Ida N, Sakurai S, Hosaka T, Hosoi K, Matsuura Y, Kohase M. An enzymelinked immunosorbent assay for the measurement of human interleukin-6. J Immunol Meth 1990;133:279-84. (Pubitemid 20338905)
14. Barrett AJ, Starkey PM. The interaction of α2 macroglobulin with proteases. Biochem J 1973;133:709-24.
15. Kanoh Y, Ohtani N, Nishikawa T, Mashiko, et al. Levels of α2 macroglobulin can predict bone metastases in prostate cancer. Anticancer Res 2001;21(1):551-6. (Pubitemid 32267569)
16. Kanoh Y, Ohtani N, Ohhara T, et al. Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, α2 macroglobulin and their complexes. Oncol Rep 2001;8:515-9.
17. Schliep G, Felgenhauer K. The α2 macroglobulin level in cerebrospinal fluid; a parameter for the concentration of the blood-CSF barrier. J Neurol 1974;207:171-81.
18. Luque A, Turu M, Juan-Babot O, et al. Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Front Biosci 2008;1(13):6483-90.
19. Moshage HJ, Roelofs HMJ, van Pelt JF, et al. The effect of interleukin-1, interleukin-6 and its interrelationships on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adalt human hepatocytes. Biochem Biophys Res 1988; 155:112-7.
20. Galimberti D, Venturelli E, Fenoglio C, et al. Intrathecal levels of IL-6, IL-11 and in Alzheimer's disease and frontotemporal lobar degeneration. J Neurol 2008;255(4):539-44.
21. Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery 2007;60(5):828-36.
22. Corrall JC, Peppel MJ, Moxon RE, Hughes TW. C-reactive protein in spinal fluid of children with meningitis. J Pediatr 1981; 99(3):365-9.
23. Gray MB, Simmonds RD, Mason H, Barnum S, Volanakis EJ. Quantitative levels of C-reactive protein in cerebrospinal fluid in patients with bacterial meningitis and other conditions. J Pediatr 1986;108:665-70. (Pubitemid 16064106)
24. Gershom BE, Briggeman-Mol JJG, Zegher DF. Cerebrospinal fluid C-reactive protein in meningitis: diagnostic value and pathophysiology. Eur J Pediatr 1986;145:246-9.
25. Steininger C, Graninger W, Zoufaly A, et al. Asymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection. Eur J Med Res 2008;13(6):304-8. (Pubitemid 351998239)
26. Ishida T, Matsuura K, Setoguchi M, Higuchi Y, Yamamoto S. Enhancement of murine serum amyloid A3 mRNA expression by glucocorticoids and its regulation by cytokines. J Leukoc Biol 1994;56(6):797-806.
27. Kindy MS, Yu J, Guo JT, Zhu H. Apolipoprotein serum amyloid A in Alzheimer'sdisease. J Alzheimers Dis 1999;1(3):155-167.